KPF
ABVX icon

K2 Principal Fund’s Abivax ABVX Stock Holding History

K2 Principal Fund’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.6M Buy
96,681
+72,278
+296% +$8.71M 0.79% 35
2026
Q2 		$3.25M Sell
24,403
-29,338
-55% -$3.32M 0.24% 122
2026
Q1 		$5.98M Buy
53,741
+31,241
+139% +$3.7M 0.42% 76
2025
Q4 		$3.03M Buy
+22,500
New +$2.45M 0.24% 121

Other funds holding ABVX

Helikon Investments
Helikon Investments London, United Kingdom $3.52B AUM 36.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $2.08B AUM 157.4% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

K2 Principal Fund's ABVX Position: Q3 2026 in Review

K2 Principal Fund increased its Abivax (ABVX) stake by 296% in Q3 2026, buying an estimated $8.71M and bringing the position to 96,681 shares worth $9.6M. The position accounts for 0.79% of the portfolio, ranked #35.

K2 Principal Fund first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • K2 Principal Fund held 96,681 shares of Abivax worth $9.6M as of Q3 2026.
  • K2 Principal Fund bought 72,278 Abivax shares in Q3 2026, an estimated $8.71M.
  • Abivax made up 0.79% of K2 Principal Fund's portfolio in Q3 2026, its #35 holding.
  • K2 Principal Fund first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on K2 Principal Fund's 13F filing for Q3 2026, filed 13 Nov 2026.